Addus HomeCare (NASDAQ:ADUS) Director Esteban Lopez Sells 250 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 250 shares of the company’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $93.00, for a total transaction of $23,250.00. Following the sale, the director owned 3,200 shares of the company’s stock, valued at $297,600. This represents a 7.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Esteban Lopez also recently made the following trade(s):

• On Tuesday, May 19th, Esteban Lopez sold 250 shares of Addus HomeCare stock. The shares were sold at an average price of $93.00, for a total transaction of $23,250.00.

Addus HomeCare Trading Down 0.7%

NASDAQ:ADUS opened at $92.65 on Friday. The company has a fifty day moving average of $95.72 and a 200 day moving average of $105.47. Addus HomeCare Corporation has a 52 week low of $89.76 and a 52 week high of $124.43. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $1.73 billion, a P/E ratio of 17.13, a P/E/G ratio of 1.28 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. During the same period in the prior year, the business earned $1.42 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. On average, research analysts predict that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. TimesSquare Capital Management LLC grew its position in Addus HomeCare by 6.2% during the 3rd quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after purchasing an additional 24,301 shares during the last quarter. Public Sector Pension Investment Board grew its position in Addus HomeCare by 14.4% during the 3rd quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock valued at $8,357,000 after purchasing an additional 8,893 shares during the last quarter. Burney Co. purchased a new stake in Addus HomeCare during the 4th quarter valued at about $1,841,000. Capital Research Global Investors grew its position in Addus HomeCare by 9.0% during the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after purchasing an additional 99,262 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in Addus HomeCare by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock valued at $153,163,000 after purchasing an additional 36,674 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ADUS. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. Citizens Jmp restated a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Barclays decreased their price objective on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Finally, Stephens decreased their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.